Calcium Gluconate Encyclopedia — Scientific Background

What Is Calcium Gluconate?

Calcium gluconate (CAS 299-28-5) is the calcium salt of D-gluconic acid, chemically designated as D-gluconic acid, calcium salt (2:1). The anhydrous form has the molecular formula C₁₂H₂₂CaO₁₄ and a molecular weight of 430.38 g/mol, while the monohydrate form has a molecular weight of 448.39 g/mol. It occurs as white, crystalline granules or powder, is odorless, and is stable in air. It is slowly soluble in water (1 g dissolves slowly in about 30 mL of water at 25°C and in about 5 mL of boiling water) and is insoluble in alcohol and many other organic solvents. Its solutions are neutral to litmus.

Regulatory Status and Pharmacopoeial Standards

Calcium gluconate holds a well-established regulatory position as both a pharmaceutical and food ingredient:

USP Monograph — The anhydrous form contains not less than 98.0% and not more than 102.0% of C₁₂H₂₂CaO₁₄, calculated on the dried basis. The monohydrate form contains not less than 98.5% and not more than 102.0% of C₁₂H₂₂CaO₁₄·H₂O where labeled as not intended for use in preparing injectable dosage forms. Calcium Gluconate intended for use in preparing injectable dosage forms is so labeled; it may also be labeled as intended for use in preparing oral dosage forms.

Food Additive — Calcium gluconate functions as an acidity regulator, firming agent, stabilizer, and thickener with the INS number 578 and E number E578. It is permitted in food with no maximum level (quantum satis) in the European Union. The FDA recognizes it as a food additive and GRAS substance under 21 CFR Parts 170–186.

Calcium Absorption Mechanisms

Intestinal calcium absorption occurs through two distinct mechanisms:

Transcellular Absorption — An active, energy-dependent process that takes place primarily in the duodenum. It is dependent on the concentration of calcium-binding proteins and is rapidly saturable. This pathway requires active vitamin D.

Paracellular Absorption — A passive, energy-independent process that occurs throughout the intestine. It is independent of calcium concentration in the gut lumen and is not rapidly saturable. This pathway is not vitamin D dependent.

Calcium gluconate is absorbed via the paracellular pathway, which does not require stomach acid for dissolution. This is why calcium gluconate is absorbed equally well with or without food and is the preferred form for individuals with hypochlorhydria or those taking acid-reducing medications.

Physiological Functions of Calcium

Calcium is the most abundant mineral in the human body, with approximately 99% stored in bones and teeth as hydroxyapatite complexes. Key physiological roles include:

• Bone Structure — Calcium provides strength and structure to bones and teeth

• Muscle Contraction — Calcium triggers the interaction between actin and myosin filaments necessary for muscle movement

• Nerve Transmission — Calcium ions are essential for neurotransmitter release at synaptic junctions

• Blood Clotting — Calcium is a cofactor for multiple clotting factors in the coagulation cascade

• Cardiovascular Function — Calcium regulates heart rhythm and vascular tone

• Hormone Secretion — Calcium signaling is required for the release of various hormones

The Bioavailability Challenge

Despite calcium's essential physiological functions, conventional oral calcium presents absorption limitations. Calcium absorption relies on tightly regulated intestinal transport systems, and increasing the administered dose does not proportionally enhance absorption efficiency. Additionally, calcium can bind with dietary inhibitors such as oxalates and phytates, which block absorption.

liposomal encapsulation addresses these limitations through a phospholipid bilayer that protects calcium from gastric degradation and dietary inhibitors, and enhances intestinal absorption through lipid-mediated pathways. liposomes protect active ingredients from being destroyed by gastric acid and digestive enzymes, and due to their affinity with cell membranes, active substances can penetrate the intestinal wall more efficiently and enter the bloodstream and cells directly.

Liposomal calcium gluconate

Liposomal encapsulation of calcium gluconate provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the calcium-gluconate complex, forming a protective shell that enhances absorption and enables targeted delivery. This delivery system:

• Protects calcium from gastric acid degradation and dietary inhibitors

• Enhances intestinal absorption through lipid-mediated pathways

• Provides sustained release with prolonged calcium elevation

• Minimizes direct contact between calcium and the gastrointestinal mucosa

The liposomal carrier facilitates "chylomicron-like" absorption, allowing for a steady release into the bloodstream and more efficient incorporation into the skeletal structure. Liposomal calcium gluconate offers excellent dispersibility in water compared to standard gluconate, making it suitable for liquid formulations including functional beverages and shots.

Clinical Evidence

Liposomal Calcium Absorption

Although clinical evidence on the application of liposomal technology to calcium absorption remains relatively limited, existing studies provide supportive insights. Previous human and animal studies have reported that liposomal formulations can increase mineral bioavailability by approximately 1.2- to 1.6-fold, which is consistent with the 1.56-fold increase in AUC observed in a human pharmacokinetic study.

A clinical trial (NCT06372158) is currently evaluating the effects of liposomal encapsulation on calcium powder absorption and metabolism in osteoporosis patients, comparing the pharmacokinetics and bioavailability of liposomal calcium versus conventional calcium formulations.

Hypocalcemia Management

Calcium gluconate is the preferred calcium salt for the management of acute symptomatic hypocalcemia, including hypocalcemic tetany, hypocalcemia related to hypoparathyroidism, and hypocalcemia due to rapid growth or pregnancy. The injectable product contains 100 mg calcium gluconate per mL, equal to 9.3 mg (0.465 mEq) elemental calcium. For oral supplementation, calcium gluconate tablets are typically dosed at 500 to 1,000 mg daily, divided into two or three doses.

Food Fortification

Calcium gluconate is widely used for the fortification of food products, including dairy products, beverages, juices, fruit concentrates, and dietary supplements, with no compromise to the sensorial properties of the fortified product. It has been evaluated for calcium enrichment of dry fermented sausages and calcium-fortified functional fruit jam.

Safety and Regulatory

Calcium gluconate is generally well tolerated. The most common side effects are gastrointestinal, including constipation and bloating, though these are less frequent with calcium gluconate than with calcium carbonate. The Tolerable Upper Intake Level (UL) for elemental calcium is 2,500 mg/day for adults aged 19–50 years and 2,000 mg/day for adults aged 51 years and older.

Calcium gluconate is Generally Recognized As Safe (GRAS) by the FDA and is an authorized food additive (E578) in the European Union with no maximum level (quantum satis). It is monographed in the USP, European Pharmacopoeia, and The International Pharmacopoeia. The Japanese Pharmacopoeia also includes a monograph for Calcium Gluconate Hydrate. Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

59$/KG